QIAGEN's CEO describes the latest sample, assay, and bioinformatics technologies that are powering life sciences and molecular diagnostics
Thierry Bernard describes the scientific advances underlying QIAGEN's four business pillars: sample technologies, diagnostic solutions, PCR, and genomics / next-generation sequencing.